跳至主要内容
临床试验/ACTRN12621000405819
ACTRN12621000405819招募中未知

Impact of early versus late artificial rupture of membranes during oxytocin induction of labour on the incidence of chorioamnionitis : A randomised controlled trial

Meghan Hill0 个研究点目标入组 500 人开始时间: 2021年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
14 Years 至 55 Years(—)
性别
Female

入选标准

  • Pregnant women with a live singleton cephalic presentation
  • Planning IOL at greater than or equal to 37 weeks gestation
  • On admission for IOL, or for after cervical ripening with intact membranes
  • Cardiotocography normal

排除标准

  • Previous caesarean delivery
  • Major fetal congenital anomaly or known chromosomal abnormality
  • Fetal growth restriction with Absent or Reverse End Diastolic Flow noted on umbilical artery Doppler (Abnormal pulsatility index of the Middle Cerebral Artery or Umbilical Artery or abnormal CPR are permissible)
  • Participant in OBLIGE Study

研究者

发起方
Meghan Hill

相似试验